Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Recruiting 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Resectable Lung Non-Small Cell Carcinoma 1Psychological Well-Being 1Parasomnias 1Fatigue 1Depression 1Anxiety Disorders 1

Interventions

Specimen Handling 642pembrolizumab 565Magnetic Resonance Spectroscopy 548Carboplatin 426Cisplatin 377Cyclophosphamide 374Biopsy 365Paclitaxel 306Nivolumab 303Gemcitabine 303Radiotherapy 274Bevacizumab 240Dexamethasone 209fludarabine 207Docetaxel 191durvalumab 183atezolizumab 177Oxaliplatin 174venetoclax 168Fluorouracil 167Rituximab 166Pemetrexed 164Capecitabine 161Radiation 159Doxorubicin 159Radiosurgery 150Etoposide 137Ipilimumab 135Leucovorin 133Lenalidomide 132

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Relaxation Therapy × 90 days × Clear all
NCT06924788 2026-05-28

VSMART

University of Alabama at Birmingham

Phase NA Enrolling by invitation
25 enrolled
Breast

Breast Neoplasms

NCT07584239 2026-05-26

Prehabilitation Physical Therapy and Relaxation Intervention Program to Promote Resiliency and Operative Success Among Adults Receiving Lung Cancer Surgery, ROAR-LCS Trial

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
30 enrolled

Resectable Lung Non-Small Cell Carcinoma

NCT01202851 2026-05-05

Relaxation for Women With Breast Cancer Undergoing Radiotherapy

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
681 enrolled
Breast

Psychological Well-Being, Breast Neoplasms, Fatigue, Parasomnias

NCT07500168 2026-03-30

MCT-FCR

Koo Foundation Sun Yat-Sen Cancer Center

Phase NA Not yet recruiting
120 enrolled

Anxiety Disorders, Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡